VIVUS, Inc. (NASDAQ:VVUS) average recommendation is hold with average Target Price of $11.50. VIVUS, Inc. (NASDAQ:VVUS) stock opened at $8.21 in last trading session, and closed at $8.17, trading in the range of $8.06 – $8.27. The stock showed a negative weekly performance of -11.00%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) CEO Jack Lief sold 100,000 shares of Arena Pharmaceuticals stock on the open market in a transaction dated Friday, January 17th. The stock was sold at an average price of $7.81, for a total transaction of $781,000.00. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares closed at $7.32 on last trade day, by losing -2.79%. Stock 52 week range is $4.05 – $9.25. Company’s market capitalization is $1.60 billion.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), the cancer-therapy developer that lost 64 percent of its market value last year, rose for a third day as investors bet the company may attract interest from larger drugmakers. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock advanced 19.55% and finished the last session at $8.99. The EPS of the stock remained -1.46. Company’s market capitalization is $1.67 billion.
Zacks reaffirmed their neutral rating on shares of MannKind Corporation (NASDAQ:MNKD) in a report released on Monday, AnalystRatings.Net reports. Zacks currently has a $5.50 price objective on the stock. MannKind Corporation (NASDAQ:MNKD) stock opened at $5.68 in last trading session and closed at $5.55. The 52 week range of the stock is $2.34 – $8.70 and the day range was $5.48 – $5.73.
Leave a Reply